Class / Patent application number | Description | Number of patent applications / Date published |
549382000 | Pentacyclo ring system having the hetero ring as one of the cyclos | 8 |
20080269510 | New alpha-glucosidase inhibitors and antibacterial compounds from Myrtus communis L. - Three new acylphloroglucinols, myrtucommulone-D (Compound 1), myrtucommulone-E (Compound 2), myrtucommulone-C (Compound 3), and a known acyphloroglucinol myrtucommulone B (Compound 4) were isolated from a methanolic extract of | 10-30-2008 |
20080306284 | Lipase Inhibitors - The present invention provides lipase inhibitors containing dimers having an epigallocatechin gallate (EGCG) unit derived from teas as well as foods and beverages and medicines containing said inhibitors. More specifically, the present invention provides lipase inhibitors containing at least one of proanthocyanidins represented by the formula: | 12-11-2008 |
20100010240 | SYNTHESIS OF POLYCYCLIC PROCYANIDINS - The invention provides compounds that are A-type procyanidins. The compounds can be prepared by reacting flavylium salts with catechins or analogs thereof, for example, under anhydrous conditions in alcohol. | 01-14-2010 |
20100056810 | 2H-CHROMENES ANNELATED AT C5-C6 AND METHODS OF MAKING AND USING THEREOF - Described herein are C | 03-04-2010 |
20120059175 | SYNTHESIS OF POLYCYCLIC PROCYANIDINS - The invention provides compounds that are A-type procyanidins. The compounds can be prepared by reacting flavylium salts with catechins or analogs thereof, for example, under anhydrous conditions in alcohol. | 03-08-2012 |
20120157696 | METHOD OF MAKING INDENO-FUSED NAPHTHOL MATERIALS - The present invention relates to a method of making indeno-fused naphthol materials, that involves, with some embodiments, forming an indanone acid intermediate, which can be represented by the following general Formula V, | 06-21-2012 |
20140018552 | USE OF COMPOUNDS ISOLATED FROM MORUS BARK - The present invention provides an AGE inhibitor and a health functional food for inhibiting an occurrence of diabetic complications. Particularly, the present invention comprises a compound selected from the group consisting of mulberrofuran G, mulberrofuran K, kuwanon G, kuwanon Z, oxyresveratrol, 2′,4′,5,7-tetrahydroxyflavanone, morusignin L and dihydromorin isolated from Morus Bark as an active ingredient. The compounds disclosed above inhibit the production of AGE which is a causative substance of diabetic complications. Thus, the compounds could be used as an AGE inhibitor and a health functional food for inhibiting diabetic nephropathy, diabetic retinopathy and diabetic neuropathy. | 01-16-2014 |
20150368224 | NOVEL ALLYL COMPOUND AND METHOD FOR PRODUCING THE SAME - The allyl compound of the present invention is represented by general formula (α): | 12-24-2015 |